Latest Exploration News

Tanami Gold NL (ASX:TAM) is raising $70.5 million through a fully underwritten renounceable rights issue priced at $0.06 per share, a 34.78% discount to the last traded price, to finance development of its Central Tanami Project.

Jindalee Lithium has locked in a strongly supported A$11 million capital raise through a placement and entitlement offer to fund its McDermitt Lithium Project and the proposed NASDAQ listing of US Elemental Inc.

Asara Resources has raised $60 million through a strongly supported institutional placement to fast-track drilling and development at its flagship Kada Gold Project in Guinea.

CZR Resources shakes up leadership with Managing Director Stefan Murphy's exit and Milan Jerkovic stepping in as Acting CEO, accompanied by the appointment of Alex Neuling as an independent director.

Mamba Exploration has identified over 20km of gold mineralisation strike at its Meeka East Gold Project, extending the Mulga Bill trend and unveiling new anomalies. The company secured up to $90,000 in co-funding from the WA Government’s Exploration Incentive Scheme to advance drilling plans.

Taiton Resources has finished drilling a single 810m diamond hole at its Yogi prospect within the Highway Project, South Australia, with assay results due in June.

Classic Minerals faces a full trial in its legal dispute over Forrestania tenements but retains 80% gold rights and asserts claims to full ownership, continuing exploration plans amid uncertainty.

Pengana International Equities (ASX:PIA) unveils a comprehensive capital management plan offering shareholders an equal-access off-market buy-back at after-tax NTA, a fully franked special dividend, and appoints Antipodes Global Investment Management to steer its portfolio.

ADX Energy’s HOCH-1 well has been deepened to 1619 metres, revealing six new thin gas sand intervals below the primary Hall Formation target. Wireline logging scheduled for 8 May will verify reservoir quality and gas saturation, with production testing to follow if results confirm the discovery’s potential.

Amplia Therapeutics and ANZGOG have initiated a clinical trial to test narmafotinib combined with chemotherapy in ovarian cancer patients unresponsive to platinum-based treatment, aiming to improve surgical outcomes and explore biomarker insights.

Regener8 Resources has closed its entitlement offer, raising $1.42 million to fund the acquisition and exploration of its Srebrenica North Project, with new shares set to begin trading next week.

Catalyst Metals continues to expand the Trident underground gold deposit with drilling results that extend mineralisation beyond current resources, underpinning a decade-long mine plan at 60,000 ounces per annum.